Peptide drugs
Search documents
WuXi AppTec(02359) - 2025 Q4 - Earnings Call Transcript
2026-03-24 02:02
WuXi AppTec (SEHK:02359) H2 2025 Earnings call March 23, 2026 09:00 PM ET Company ParticipantsFlorence Shi - SVP and CFOMinzhang Chen - Co-CEORuijia Tang - IR DirectorSteve Yang - Co-CEOConference Call ParticipantsLaurence Tam - Healthcare, Pharma, and Biotech Research AnalystLaurence TamHi. Good morning, everyone, for those who are based in China and Hong Kong, and good evening for those based in the U.S. This is the 2025 WuXi AppTec results call. My name is Laurence Tam. I'm a China healthcare analyst at ...